Body Contouring in Akita Japan
Body Contouring in Akita section, includes general infrmation about Body Contouring Procedure, Body Contouring Akita Local News, Body Contouring Akita Surgeon Locator and other Body Contouring related material.
Akita Body Contouring - The Procedure
This procedure can help you to dramatically improve your appearance. It is usually the next step after excessive weight reduction or bariatric surgery. When you loose weight quickly your skin cannot return to the new size as quickly resulting in extra skin is areas such as the abdomen, upper arms, thighs and breasts. Sometimes your skin is not elastic enough due to aging process, which can lead to permanent skin flaps. It can also be done to repair the effects of childbearing and aging. The extra skin can cause hygiene problems, avoiding cloth with short sleeves and low self-esteem. Body contouring is a series of operation, which can be divided into two groups, lower body lift and upper body lift. The lower body lift deals with your abdomen thighs and buttocks. Upper body lift is complementary to the lower body lift and it deals with breast and upper arms. The ideal candidates for the surgery are people in good general health who are unsatisfied with their body appearance.
Akita Body Contouring - OperationDuring the surgery usually the abdomen is treated first, because it is the area with the most excess of skin and fat. A horizontal incision is made above the pubic area, through which the extra fat is removed and the muscles are tightened. In some cases liposuction is performed to remove extra fat. Thighs and butt are treated by the same principle. The operation lasts from 4-7 hours and performed under general anesthesia. Sometimes additional procedures are done during the same operation; those include breast lift, arm lift or inner thigh lift. Arm lift is done by placing an incision from the armpit to the elbow and by removing extra fat and skin. The excess fat from the inner thigh is removed by liposuction, the incision usually made between the groin and the upper thigh.
Akita Body Contouring - Risks
Every procedure has its risks. The most common complication of body lift is seroma formation. Other complications such as bleeding, infection or blood clots are relatively rare. The scars never completely disappear, but they fade with time and change their size. This can take several months until the scars take their final appearance.
Akita Body Contouring - Healing
This is a serious procedure, which takes some time to heal. Many people require 4-6 weeks before returning to their daily activities. You shouldn't exercise or lift heavy weight 6-8 weeks. The swelling usually completely disappears after 3 month. It is important to wear special garments to assure proper healing.
Other Body Contouring Procedures
All Body Procedures
Body Contouring akita (current)
akita Buttock Augmentation
akita Calf Augmentation
akita Liposuction
akita Body Contouring
More Akita info...
Akita By plane
Akita has an airport, with domestic flights coming in from such places as Tokyo, Nagoya, Osaka and Sapporo. Buses connect the airport with Akita station (40 minutes, ¥890).
-
Akita By train
The Akita Shinkansen provides hourly service from Tokyo station to Akita station. Trains are all-reserved and are known as Komachi (???) trains. The trains only stop at Ueno, Omiya, Sendai and Morioka before slowing down to travel to Akita over conventional rail lines. Trains also reverse direction once at Omagari, the stop before Akita.
Komachi trains from Tokyo reach Akita in four hours and cost ¥16810 each way, so it might be wise to get a rail pass of some kind before making the journey. Beware that the Komachi trains are coupled to Hachinohe-bound Hayate trains, which split at Morioka, but as all seats are reserved the chance of getting in the wrong car is minimal at best.
-
Plastic Surgery News...
- Mood disorders could be caused by a loss of our inherent, reflexive avoidance of aversive events, according to a study published in PLoS Computational Biology. Researchers from UCL in London and Columbia University in New York used computational modeling techniques to integrate what appeared to be blatant contradictions between serotonin's roles in different states of health.
Context Individuals with diabetes are at increased risk for cardiovascular disease (CVD), but more aggressive targets for risk factor control have not been tested.
Objective To compare progression of subclinical atherosclerosis in adults with type 2 diabetes treated to reach aggressive targets of low-density lipoprotein cholesterol (LDL-C) of 70 mg/dL or lower and systolic blood pressure (SBP) of 115 mm Hg or lower vs standard targets of LDL-C of 100 mg/dL or lower and SBP of 130 mm Hg or lower.
Design, Setting, and Participants A randomized, open-label, blinded-to-end point, 3-year trial from April 2003-July 2007 at 4 clinical centers in Oklahoma, Arizona, and South Dakota. Participants were 499 American Indian men and women aged 40 years or older with type 2 diabetes and no prior CVD events.
Interventions Participants were randomized to aggressive (n=252) vs standard (n=247) treatment groups with stepped treatment algorithms defined for both.
Main Outcome Measures Primary end point was progression of atherosclerosis measured by common carotid artery intimal medial thickness (IMT). Secondary end points were other carotid and cardiac ultrasonographic measures and clinical events.
Results Mean target LDL-C and SBP levels for both groups were reached and maintained. Mean (95% confidence interval) levels for LDL-C in the last 12 months were 72 (69-75) and 104 (101-106) mg/dL and SBP levels were 117 (115-118) and 129 (128-130) mm Hg in the aggressive vs standard groups, respectively. Compared with baseline, IMT regressed in the aggressive group and progressed in the standard group (–0.012 mm vs 0.038 mm; P < .001); carotid arterial cross-sectional area also regressed (–0.02 mm2 vs 1.05 mm2; P < .001); and there was greater decrease in left ventricular mass index (–2.4 g/m2.7 vs –1.2 g/m2.7; P = .03) in the aggressive group. Rates of adverse events (38.5% and 26.7%; P = .005) and serious adverse events (n = 4 vs 1; P = .18) related to blood pressure medications were higher in the aggressive group. Clinical CVD events (1.6/100 and 1.5/100 person-years; P = .87) did not differ significantly between groups.
Conclusions Reducing LDL-C and SBP to lower targets resulted in regression of carotid IMT and greater decrease in left ventricular mass in individuals with type 2 diabetes. Clinical events were lower than expected and did not differ significantly between groups. Further follow-up is needed to determine whether these improvements will result in lower long-term CVD event rates and costs and favorable risk-benefit outcomes.
Trial Registration clinicaltrials.gov Identifier: NCT00047424